A Randomized, Open-Label, Comparative, Two-Treatment, Crossover Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects on Days 1 and 5 of Intravenous Treatment.
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2010
At a glance
- Drugs Esomeprazole; Lansoprazole
- Indications Gastro-oesophageal reflux
- Focus Pharmacodynamics
- 01 Apr 2009 Actual end date (1 Feb 2006) added as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.